DOJ trends highlight AI risks in healthcare - BioXconomy
DOJ warns of AI risks in patient care, third-party compliance, and whistleblower-driven healthcare cases.
BioXconomy 4
Covers: HealthcareRegulation & PolicyGovernance & Risk Management
Former Regulator Warns of AI Enforcement Risks - BioXconomy
AI risks hit biopharma after settlement ... Expert warns that unchecked use of AI can lead to significant risk, including regulatory violations and ...
eClinical Solutions and ZS join forces to advance risk -based quality management
... risk management , quality assurance, and clinical trial operations. The partnership integrates eClinical's AI -powered platform with ZS's consulting ...
AI's impact on pharma and compliance functions
During the panel, “Utilize AI to Enhance Oversight, Efficiency and Risk Mitigation,” Laham addressed the current state of AI adoption, ...